TapImmune to Present at Two Upcoming Investor Conferences

JACKSONVILLE, Florida – September 25, 2018 – TapImmune Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company, today announced that its President and CEO, Peter L. Hoang, will participate at two upcoming investor conferences.  Mr. Hoang will present at the Cantor Global Healthcare Conference, to be held October 1-3, 2018, in New York City, and will present and participate in Advances in Cell and Gene Therapies Panel at the Sachs Associates 18th Annual Biotech in Europe Forum, to be held October 4-5, 2018, in Basel, Switzerland.  Cantor Global Healthcare Conference: Date: Monday, October 1, 2018 Location: Intercontinental New York Barclay Hotel; New York, NY Time: 3:30pm (ET): Track 6 – Rockefeller Suite  Sachs Associates 18th Annual Biotech in Europe Forum Date: Thursday, October 4, 2018 Location: The Congress Center Basel; Basel, Switzerland Time: 11:30am (CEST): Panel – Advances in Cell & Gene Therapies 4:05pm (CEST): Company Presentation Both events will be webcast, available at https://tapimmune.com/events/.[/vc_column_text][vc_empty_space height=”4px”][vc_column_text][pr-disclaimer2]